Connection

Philip Howe to Transforming Growth Factor beta

Back to Details
This is a "connection" page, showing publications Philip Howe has written about Transforming Growth Factor beta.
Philip Howe
Connection Strength
8.174
Transforming Growth Factor beta
  1. TGF?-induced expression of long noncoding lincRNA Platr18 controls breast cancer axonogenesis. Life Sci Alliance. 2022 02; 5(2).
    View in: PubMed
    Score: 0.630
  2. TGF? promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis. Oncogene. 2019 05; 38(20):3794-3811.
    View in: PubMed
    Score: 0.518
  3. TGF-beta signaling in cancer: post-transcriptional regulation of EMT via hnRNP E1. Cytokine. 2019 06; 118:19-26.
    View in: PubMed
    Score: 0.484
  4. Cathepsin-B-mediated cleavage of Disabled-2 regulates TGF-?-induced autophagy. Nat Cell Biol. 2016 08; 18(8):851-63.
    View in: PubMed
    Score: 0.434
  5. Identification and characterization of an hnRNP E1 translational silencing motif. Nucleic Acids Res. 2016 07 08; 44(12):5892-907.
    View in: PubMed
    Score: 0.427
  6. Translational regulation of inhibin ?A by TGF? via the RNA-binding protein hnRNP E1 enhances the invasiveness of epithelial-to-mesenchymal transitioned cells. Oncogene. 2016 Mar 31; 35(13):1725-35.
    View in: PubMed
    Score: 0.404
  7. Establishment of a TGF?-induced post-transcriptional EMT gene signature. PLoS One. 2012; 7(12):e52624.
    View in: PubMed
    Score: 0.339
  8. TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI. Nat Cell Biol. 2010 Mar; 12(3):286-93.
    View in: PubMed
    Score: 0.279
  9. The tale of transforming growth factor-beta (TGFbeta) signaling: a soign? enigma. IUBMB Life. 2009 Oct; 61(10):929-39.
    View in: PubMed
    Score: 0.271
  10. Runx1 is a co-activator with FOXO3 to mediate transforming growth factor beta (TGFbeta)-induced Bim transcription in hepatic cells. J Biol Chem. 2009 Jul 24; 284(30):20227-39.
    View in: PubMed
    Score: 0.265
  11. Transforming growth factor beta (TGFbeta)-induced apoptosis: the rise & fall of Bim. Cell Cycle. 2009 Jan 01; 8(1):11-7.
    View in: PubMed
    Score: 0.258
  12. TGF beta-mediated BIM expression and apoptosis are regulated through SMAD3-dependent expression of the MAPK phosphatase MKP2. EMBO Rep. 2008 Oct; 9(10):990-7.
    View in: PubMed
    Score: 0.251
  13. Disabled-2 (Dab2) mediates transforming growth factor beta (TGFbeta)-stimulated fibronectin synthesis through TGFbeta-activated kinase 1 and activation of the JNK pathway. J Biol Chem. 2005 Jul 08; 280(27):25920-7.
    View in: PubMed
    Score: 0.200
  14. Disabled-2 (Dab2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (EMT). J Biol Chem. 2005 Apr 29; 280(17):17540-8.
    View in: PubMed
    Score: 0.197
  15. Smad3 potentiates transforming growth factor beta (TGFbeta )-induced apoptosis and expression of the BH3-only protein Bim in WEHI 231 B lymphocytes. J Biol Chem. 2003 May 16; 278(20):18069-77.
    View in: PubMed
    Score: 0.172
  16. Smad7 is induced by CD40 and protects WEHI 231 B-lymphocytes from transforming growth factor-beta -induced growth inhibition and apoptosis. J Biol Chem. 2000 Dec 08; 275(49):38363-70.
    View in: PubMed
    Score: 0.147
  17. Analysis of TGF-beta-mediated synthesis of extracellular matrix components. Methods Mol Biol. 2000; 142:55-65.
    View in: PubMed
    Score: 0.138
  18. Promoter analysis of TGF-beta responsive genes by transient transfection and deletional/mutational analysis. Methods Mol Biol. 2000; 142:79-95.
    View in: PubMed
    Score: 0.138
  19. Regulation of AP-1 activity by TGF-beta. Methods Mol Biol. 2000; 142:97-108.
    View in: PubMed
    Score: 0.138
  20. Analysis of TGF-beta-inducible apoptosis. Methods Mol Biol. 2000; 142:149-67.
    View in: PubMed
    Score: 0.138
  21. Transforming growth factor beta induces caspase 3-independent cleavage of alphaII-spectrin (alpha-fodrin) coincident with apoptosis. J Biol Chem. 1999 Aug 13; 274(33):23256-62.
    View in: PubMed
    Score: 0.134
  22. Transforming growth factor beta regulates clusterin gene expression via modulation of transcription factor c-Fos. Eur J Biochem. 1999 Jul; 263(2):534-42.
    View in: PubMed
    Score: 0.133
  23. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 1999 Mar 01; 18(5):1345-56.
    View in: PubMed
    Score: 0.130
  24. Caspase inhibitor BD-fmk distinguishes transforming growth factor beta-induced apoptosis from growth inhibition. Cell Growth Differ. 1998 Oct; 9(10):869-75.
    View in: PubMed
    Score: 0.127
  25. The Long (lncRNA) and Short (miRNA) of It: TGF?-Mediated Control of RNA-Binding Proteins and Noncoding RNAs. Mol Cancer Res. 2018 04; 16(4):567-579.
    View in: PubMed
    Score: 0.122
  26. Mechanisms of TGF-beta-induced cell cycle arrest. Miner Electrolyte Metab. 1998; 24(2-3):131-5.
    View in: PubMed
    Score: 0.120
  27. Regulation of clusterin gene expression by transforming growth factor beta. J Biol Chem. 1997 Oct 17; 272(42):26620-6.
    View in: PubMed
    Score: 0.119
  28. Membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-? signaling. J Clin Invest. 2017 Apr 03; 127(4):1321-1337.
    View in: PubMed
    Score: 0.114
  29. Surface Expression of TGF? Docking Receptor GARP Promotes Oncogenesis and Immune Tolerance in Breast Cancer. Cancer Res. 2016 12 15; 76(24):7106-7117.
    View in: PubMed
    Score: 0.111
  30. Isolation and characterization of mutant cell lines defective in transforming growth factor beta signaling. Proc Natl Acad Sci U S A. 1996 Jul 23; 93(15):7655-60.
    View in: PubMed
    Score: 0.109
  31. Transforming growth factor beta (TGF beta)-induced nuclear localization of apolipoprotein J/clusterin in epithelial cells. Biochemistry. 1996 May 14; 35(19):6157-63.
    View in: PubMed
    Score: 0.107
  32. Transforming Growth Factor-? Is an Upstream Regulator of Mammalian Target of Rapamycin Complex 2-Dependent Bladder Cancer Cell Migration and Invasion. Am J Pathol. 2016 05; 186(5):1351-60.
    View in: PubMed
    Score: 0.106
  33. Inhibition of G1 phase cyclin dependent kinases by transforming growth factor beta 1. J Cell Biochem. 1994 Nov; 56(3):418-25.
    View in: PubMed
    Score: 0.097
  34. Release from G1 growth arrest by transforming growth factor beta 1 requires cellular ras activity. J Biol Chem. 1993 Oct 05; 268(28):21448-52.
    View in: PubMed
    Score: 0.090
  35. Transforming growth factor beta 1-mediated inhibition of smooth muscle cell proliferation is associated with a late G1 cell cycle arrest. J Cell Physiol. 1993 Jul; 156(1):48-55.
    View in: PubMed
    Score: 0.088
  36. Loss of transforming growth factor beta 1 (TGF-beta 1)-induced growth arrest and p34cdc2 regulation in ras-transfected epithelial cells. Oncogene. 1992 Aug; 7(8):1549-56.
    View in: PubMed
    Score: 0.083
  37. Myosin II isoform switching mediates invasiveness after TGF-?-induced epithelial-mesenchymal transition. Proc Natl Acad Sci U S A. 2011 Nov 01; 108(44):17991-6.
    View in: PubMed
    Score: 0.078
  38. 3'-UTR-mediated post-transcriptional regulation of cancer metastasis: beginning at the end. RNA Biol. 2011 Jul-Aug; 8(4):595-9.
    View in: PubMed
    Score: 0.077
  39. Transforming growth factor beta 1 inhibition of p34cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest. Mol Cell Biol. 1991 Mar; 11(3):1185-94.
    View in: PubMed
    Score: 0.075
  40. Identification of an mRNP complex regulating tumorigenesis at the translational elongation step. Mol Cell. 2011 Feb 18; 41(4):419-31.
    View in: PubMed
    Score: 0.075
  41. The inhibitory effects of Disabled-2 (Dab2) on Wnt signaling are mediated through Axin. Oncogene. 2008 Mar 20; 27(13):1865-75.
    View in: PubMed
    Score: 0.059
  42. Secreted transforming growth factor beta2 activates NF-kappaB, blocks apoptosis, and is essential for the survival of some tumor cells. Proc Natl Acad Sci U S A. 2004 May 04; 101(18):7112-7.
    View in: PubMed
    Score: 0.047
  43. The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation. J Biol Chem. 2003 Jul 11; 278(28):26249-57.
    View in: PubMed
    Score: 0.044
  44. TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J Immunol. 1997 Mar 01; 158(5):2065-75.
    View in: PubMed
    Score: 0.028
  45. Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFbeta-treated cells. Nature. 1996 Mar 21; 380(6571):262-5.
    View in: PubMed
    Score: 0.027
  46. Inhibition of interferon-gamma-induced major histocompatibility complex class II gene transcription by interferon-beta and type beta 1 transforming growth factor in human astrocytoma cells. Definition of cis-element. J Biol Chem. 1993 Sep 05; 268(25):18794-800.
    View in: PubMed
    Score: 0.022
  47. Central role for disabled-2 in mesenchymal stem cardiac protein expression and functional consequences after engraftment in acute myocardial infarction. Stem Cells Dev. 2011 Apr; 20(4):681-93.
    View in: PubMed
    Score: 0.018
  48. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2. J Biol Chem. 1996 Jul 26; 271(30):17791-7.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.